Search
Search
About
Log in
Join
Experiences with
Enzalutamide
Posts
Communities
802 public posts
Filter results
Trade Zytiga for Enzalutamide or darolutamide
I am switching from Zytiga, to
enzalutamide
or darolutamide . I have a couple of bottles of 500 mg Zytiga, 60 tablets per bottle And would like to swap for the same of
Enzalutamide
or darolutamide.
I am switching from Zytiga, to
enzalutamide
or darolutamide . I have a couple of bottles of 500 mg Zytiga, 60 tablets per bottle And would like to swap for the same of
Enzalutamide
or darolutamide.
Farmhand
in
Advanced Prostate Cancer
9 months ago
Enzalutamide approved for patients with high risk of metastasis
https://www.onclive.com/view/fda-approves-
enzalutamide
-for-nmcspc-with-high-risk-biochemical-recurrence
https://www.onclive.com/view/fda-approves-
enzalutamide
-for-nmcspc-with-high-risk-biochemical-recurrence
Maxone73
in
Advanced Prostate Cancer
8 months ago
Dad’s blood reports. PSA and testosterone down but ALP up
He has been taking Relugolix from 8th June - 18 days And is supposed to start
enzalutamide
from this week He had upper pain in one leg where there are mets in ischeum and femur.
He has been taking Relugolix from 8th June - 18 days And is supposed to start
enzalutamide
from this week He had upper pain in one leg where there are mets in ischeum and femur.
Tinkudi
in
Advanced Prostate Cancer
25 days ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
HELP WITH SIDE EFFECTS FROM ENZALUTAMIDE
I now want to discontinue taking
enzalutamide
. My PSA went down from 5.2 to 0.4 so the treatment is working it is just that the side effects are severely affecting my quality of life.
I now want to discontinue taking
enzalutamide
. My PSA went down from 5.2 to 0.4 so the treatment is working it is just that the side effects are severely affecting my quality of life.
Desrochers
in
Advanced Prostate Cancer
6 months ago
Adaptive dosing: very promising results with Enzalutamide + Lutetium
https://www.urotoday.com/video-lectures/esmo-2023/video/3699-enza-p-trial-shows-promise-for-
enzalutamide
-lutetium-combination-in-prostate-cancer-louise-emmett.html
https://www.urotoday.com/video-lectures/esmo-2023/video/3699-enza-p-trial-shows-promise-for-
enzalutamide
-lutetium-combination-in-prostate-cancer-louise-emmett.html
Maxone73
in
Advanced Prostate Cancer
8 months ago
Orgovyx and enzalutamide
Can anyone tell me if Orgovyx and Xtandi are paid by Medicare Part B or the drug plan part D. If Part D, Is Wellcare a good plan to use?
Can anyone tell me if Orgovyx and Xtandi are paid by Medicare Part B or the drug plan part D. If Part D, Is Wellcare a good plan to use?
shihtzu124
in
Advanced Prostate Cancer
8 months ago
Dual Action Hormone Therapy Targeting Two Parts of Androgen Receptor for mCRPC
Phase I/II trial of masofaniten combined with
enzalutamide
, a novel hormonal therapy for mCRPC. Masofaniten, a first-in-class N-terminal ligand antagonist for the androgen receptor, shows promise in overcoming resistance to current hormonal therapies. Hopefully a new weapon for us!
Phase I/II trial of masofaniten combined with
enzalutamide
, a novel hormonal therapy for mCRPC. Masofaniten, a first-in-class N-terminal ligand antagonist for the androgen receptor, shows promise in overcoming resistance to current hormonal therapies. Hopefully a new weapon for us!
Maxone73
in
Advanced Prostate Cancer
8 months ago
EPIX: Updated Data From Phase 1 Trial Of Masofaniten And Enzalutamide Expected
Source link : https://scr.zacks.com/news/news-details/2024/EPIX-Updated-Data-from-Phase-1-Trial-of-Masofaniten-and-
Enzalutamide
-Expected-in-2H24-article/default.aspx The median PSA baseline for this study was 3.2 ng/mL, which on the surface may look like it is quite different from the other studies
Source link : https://scr.zacks.com/news/news-details/2024/EPIX-Updated-Data-from-Phase-1-Trial-of-Masofaniten-and-
Enzalutamide
-Expected-in-2H24-article/default.aspx The median PSA baseline for this study was 3.2 ng/mL, which on the surface may look like it is quite different from the other studies
God_Loves_Me
in
Advanced Prostate Cancer
2 months ago
Testosterone was nearly back to normal, then dropped
I had a year of Lupron and
Enzalutamide
in 2022. Testosterone slowly came back to a high of about 240 in June and Sept 2023. Normal for me is around 350 - 375. Now this week T is down to 156. Is this sort of fluctuation normal?
I had a year of Lupron and
Enzalutamide
in 2022. Testosterone slowly came back to a high of about 240 in June and Sept 2023. Normal for me is around 350 - 375. Now this week T is down to 156. Is this sort of fluctuation normal?
Teddy28
in
Advanced Prostate Cancer
6 months ago
Advanced Prostate Cancer to bone and liver
Patient switched to
enzalutamide
early 2023, secondary to rising PSA. Initiation of Taxotere and prednisone June 2023, for metastatic disease. Zometa for bone metastases. Treatment holiday March 2024 - May 2024, without evidence of progression. Taxotere had been reduced to 60 mg/m2 dosing.
Patient switched to
enzalutamide
early 2023, secondary to rising PSA. Initiation of Taxotere and prednisone June 2023, for metastatic disease. Zometa for bone metastases. Treatment holiday March 2024 - May 2024, without evidence of progression. Taxotere had been reduced to 60 mg/m2 dosing.
swelnetz
in
Advanced Prostate Cancer
26 days ago
Triplet Therapy
If I did triplet therapy ADT/DOCXATEL/
ENZALUTAMIDE
is it possible the
ENZALUTAMIDE
could be effective even though the Daralutamide was not?
If I did triplet therapy ADT/DOCXATEL/
ENZALUTAMIDE
is it possible the
ENZALUTAMIDE
could be effective even though the Daralutamide was not?
Joeym1040
in
Advanced Prostate Cancer
9 months ago
Father’s CRPCa Failed chemo (Cabazitaxel,Docetaxel) and Failed LU177
Failed Drug vacation 2023 July to 2023 September - PSA rose to 269. 2023 Sep - 2023 Nov
Enzalutamide
Ineffective … and stopped due to severe side effects. 2023 Dec PSA increased to 357. Started Cabazitaxel on December 27, 2023. 2nd dose on January 16th, 2024 and 3rd dose on February 6th, 2024.
Failed Drug vacation 2023 July to 2023 September - PSA rose to 269. 2023 Sep - 2023 Nov
Enzalutamide
Ineffective … and stopped due to severe side effects. 2023 Dec PSA increased to 357. Started Cabazitaxel on December 27, 2023. 2nd dose on January 16th, 2024 and 3rd dose on February 6th, 2024.
Vishwa1890
in
Advanced Prostate Cancer
5 months ago
Introduction and asking for help interpreting latest scan results and thoughts on future treatment plan please.
Current recommended treatment plan is Lupron shots, either Abiraterone acetate along with Prednisone or
Enzalutamide
. Also have a consultation with the radiation oncologist scheduled for next week. Thoughts and opinion on treatment plan very much appreciated?
Current recommended treatment plan is Lupron shots, either Abiraterone acetate along with Prednisone or
Enzalutamide
. Also have a consultation with the radiation oncologist scheduled for next week. Thoughts and opinion on treatment plan very much appreciated?
APCFighter
in
Advanced Prostate Cancer
11 days ago
European Society for Medical Oncology Congress - ESMO 2023 - Two Significant Lutetium Trials -mCRPC
This phase 2 randomised trial of
Enzalutamide
and Lu-PSMA-617, in poor risk mCRPC evaluated the activity and safety of combining
enzalutamide
with adaptive dosing of LuPSMA vs
enzalutamide
alone as first line treatment for mCRPC.
This phase 2 randomised trial of
Enzalutamide
and Lu-PSMA-617, in poor risk mCRPC evaluated the activity and safety of combining
enzalutamide
with adaptive dosing of LuPSMA vs
enzalutamide
alone as first line treatment for mCRPC.
marnieg46
in
Fight Prostate Cancer
9 months ago
Cabazitaxel or Phase 1 drug trial
RP 2008, Bicalutimide 2008 until 2019,
Enzalutamide
2019 - 2022, Zoladex 3 monthly implant 2019 ongoing. Phase 1 drug trial at Royal Marsden in London Jan 2023 - June 2023 (failed). Doxetaxel August 2023 - November 2023 - but gave up after 5 infusion as it was clearly not working.
RP 2008, Bicalutimide 2008 until 2019,
Enzalutamide
2019 - 2022, Zoladex 3 monthly implant 2019 ongoing. Phase 1 drug trial at Royal Marsden in London Jan 2023 - June 2023 (failed). Doxetaxel August 2023 - November 2023 - but gave up after 5 infusion as it was clearly not working.
Petertanner
in
Advanced Prostate Cancer
7 months ago
One last push ..please...help for my Dad. NHS treatments no longer viable - Pca stage 4.
Sept 2023 - Jan 2024 -
Enzalutamide
. Sept 2023 - Radiotherapy C7-T4, T7-T9.
Sept 2023 - Jan 2024 -
Enzalutamide
. Sept 2023 - Radiotherapy C7-T4, T7-T9.
kikinini
in
Advanced Prostate Cancer
7 days ago
Phase 3 trial enrolling: MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in participants with mCRPC
Previously Treated With Next-generation Hormonal Agent (NHA) and Taxane-based Chemotherapy...which would be the case for people that did the triplet. It's the "old" ODM-208 molecule! https://uvahealth.com/clinicaltrials/phase-3-randomized-open-label-study-mk-5684-versus-alternative-abiraterone-acetate
Previously Treated With Next-generation Hormonal Agent (NHA) and Taxane-based Chemotherapy...which would be the case for people that did the triplet. It's the "old" ODM-208 molecule! https://uvahealth.com/clinicaltrials/phase-3-randomized-open-label-study-mk-5684-versus-alternative-abiraterone-acetate
Maxone73
in
Advanced Prostate Cancer
1 month ago
Does this mark the beginning of castration resistance?
Since May 2023, dad has been on monthly Degarelix (Firmagon) injections and on a regime of 160 mg of
Enzalutamide
daily (Xtandi). His PSA reached a nadir of 0.02 in March 2024. Most recent PSA in April 2024 showed an PSA increase to 0.03 with testosterone value of 0.41 ng/ml.
Since May 2023, dad has been on monthly Degarelix (Firmagon) injections and on a regime of 160 mg of
Enzalutamide
daily (Xtandi). His PSA reached a nadir of 0.02 in March 2024. Most recent PSA in April 2024 showed an PSA increase to 0.03 with testosterone value of 0.41 ng/ml.
Agh-2022
in
Advanced Prostate Cancer
3 months ago
EMBARK Study: ADT vs Enzalutamide +/- ADT
The efficacy and safety of
enzalutamide
plus an- drogen-deprivation therapy and
enzalutamide
monotherapy, as compared with androgen-deprivation therapy alone, are unknown.
The efficacy and safety of
enzalutamide
plus an- drogen-deprivation therapy and
enzalutamide
monotherapy, as compared with androgen-deprivation therapy alone, are unknown.
MateoBeach
in
Advanced Prostate Cancer
9 months ago
EMBARK Study: Enzalutamide +/- ADT
The efficacy and safety of
enzalutamide
plus an- drogen-deprivation therapy and
enzalutamide
monotherapy, as compared with androgen-deprivation therapy alone, are unknown.
The efficacy and safety of
enzalutamide
plus an- drogen-deprivation therapy and
enzalutamide
monotherapy, as compared with androgen-deprivation therapy alone, are unknown.
MateoBeach
in
Fight Prostate Cancer
9 months ago
1
2
3
4
...
41
Next page
10
20
30
40
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
731 results
Fight Prostate Cancer
54 results
Prostate Cancer Network
7 results
View top 10 communities
Sort by
Most Relevant
Newest